There is currently a global push by the biotechnology industry to deregulate a variety of new genetic modification (GM) techniques – often referred to by industry as ‘gene editing’ or ‘new plant breeding techniques’. These include techniques such as CRISPR, zinc finger nucleases and oligo-directed mutagenesis. However, if these techniques were to be deregulated in Australia before being approved in key export markets the market impacts could be catastrophic.

Download Document